As of 2026-09-13, the EV/EBITDA ratio of Biosynex SA (ALBIO.PA) is -13.47. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBIO.PA's latest enterprise value is 73.95 mil EUR. ALBIO.PA's TTM EBITDA according to its financial statements is -5.49 mil EUR. Dividing these 2 quantities gives us the above ALBIO.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 7.9x | 6.5x |
| Forward P/E multiples | 5.2x - 8.7x | 7.0x |
| Fair Price | (4.58) - (5.37) | (5.01) |
| Upside | -607.4% - -695.1% | -655.7% |
| Date | EV/EBITDA |
| 2026-09-04 | -13.43 |
| 2026-09-03 | -13.40 |
| 2026-09-02 | -13.39 |
| 2026-09-01 | -13.44 |
| 2026-08-31 | -13.45 |
| 2026-08-28 | -13.46 |
| 2026-08-27 | -13.53 |
| 2026-08-26 | -13.45 |
| 2026-08-25 | -13.47 |
| 2026-08-24 | -13.51 |
| 2026-08-21 | -13.55 |
| 2026-08-20 | -13.60 |
| 2026-08-19 | -13.51 |
| 2026-08-18 | -13.56 |
| 2026-08-17 | -13.58 |
| 2026-08-14 | -13.56 |
| 2026-08-13 | -13.80 |
| 2026-08-12 | -13.80 |
| 2026-08-11 | -13.49 |
| 2026-08-10 | -13.49 |
| 2026-08-07 | -13.47 |
| 2026-08-06 | -13.48 |
| 2026-08-05 | -13.47 |
| 2026-08-04 | -13.49 |
| 2026-08-03 | -13.53 |
| 2026-07-31 | -13.53 |
| 2026-07-30 | -13.47 |
| 2026-07-29 | -13.49 |
| 2026-07-28 | -13.53 |
| 2026-07-27 | -13.60 |
| 2026-07-24 | -13.53 |
| 2026-07-23 | -13.57 |
| 2026-07-22 | -13.59 |
| 2026-07-21 | -13.56 |
| 2026-07-20 | -13.49 |
| 2026-07-17 | -13.43 |
| 2026-07-16 | -13.46 |
| 2026-07-15 | -13.47 |
| 2026-07-14 | -13.49 |
| 2026-07-13 | -13.46 |
| 2026-07-10 | -13.41 |
| 2026-07-09 | -13.43 |
| 2026-07-08 | -13.46 |
| 2026-07-07 | -13.42 |
| 2026-07-06 | -13.47 |
| 2026-07-03 | -13.45 |
| 2026-07-02 | -13.47 |
| 2026-07-01 | -13.49 |
| 2026-06-30 | -13.47 |
| 2026-06-29 | -13.47 |